Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

SII

Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAXPTIOct 30, 2021 10:03 AM +05:30 IST
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: ReportSwarajya StaffOct 1, 2021 10:32 AM +05:30 IST
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six Months
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six MonthsSwarajya StaffAug 14, 2021 12:27 PM +05:30 IST
Govt Places Order For 66 Crore COVID-19 Vaccine Doses From Serum Institute, Bharat Biotech
Govt Places Order For 66 Crore COVID-19 Vaccine Doses From Serum Institute, Bharat BiotechSwarajya StaffJul 16, 2021 09:47 AM +05:30 IST
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: Report
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: ReportSwarajya StaffJun 18, 2021 04:18 PM +05:30 IST
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent Efficacy
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent EfficacySwarajya StaffJun 15, 2021 03:06 PM +05:30 IST
Govt's Expert Panel Mulls Increasing Gap Between Covishield's Two Doses To Boost Efficacy, Vaccination Drive
Govt's Expert Panel Mulls Increasing Gap Between Covishield's Two Doses To Boost Efficacy, Vaccination DriveSwarajya StaffMay 7, 2021 10:02 AM +05:30 IST
Covishield May Offer Protection Against Double Mutant Strain: CCMB Report
Covishield May Offer Protection Against Double Mutant Strain: CCMB ReportIANSApr 23, 2021 05:09 PM +05:30 IST
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By DussehraSwarajya StaffApr 20, 2021 06:40 PM +05:30 IST
Lift Embargo On Vaccine Raw Material Exports: Serum Institute's Adar Poonawalla Urges US President Biden
Lift Embargo On Vaccine Raw Material Exports: Serum Institute's Adar Poonawalla Urges US President BidenSwarajya StaffApr 16, 2021 03:46 PM +05:30 IST
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening? Suraj SApr 13, 2021 02:09 PM +05:30 IST
WHO Approves Two Versions Of Oxford-AstraZeneca Covid-19 Vaccine Including SII's Covishield For Emergency Use
WHO Approves Two Versions Of Oxford-AstraZeneca Covid-19 Vaccine Including SII's Covishield For Emergency UseSwarajya StaffFeb 16, 2021 12:59 PM +05:30 IST
Health Ministry Says It Doesn't Agree With Calculation Of Rs 80,000 Crore For Covid-19 Vaccine Distribution
Health Ministry Says It Doesn't Agree With Calculation Of Rs 80,000 Crore For Covid-19 Vaccine DistributionSwarajya StaffSep 30, 2020 08:10 AM +05:30 IST
After Oxford Covid-19 Vaccine, Serum Institute Likely To Start Clinical Trials Of Novavax's Vaccine Candidate In India
After Oxford Covid-19 Vaccine, Serum Institute Likely To Start Clinical Trials Of Novavax's Vaccine Candidate In IndiaSwarajya StaffSep 17, 2020 10:48 AM +05:30 IST
Serum Institute To Begin Human Clinical Trials Of Oxford University's Covid-19 Vaccine In India From Today
Serum Institute To Begin Human Clinical Trials Of Oxford University's Covid-19 Vaccine In India From TodaySwarajya StaffAug 25, 2020 01:00 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype